ATE203677T1 - Legionellosis-impfstoffe und verfahren zur deren herstellung - Google Patents

Legionellosis-impfstoffe und verfahren zur deren herstellung

Info

Publication number
ATE203677T1
ATE203677T1 AT96112524T AT96112524T ATE203677T1 AT E203677 T1 ATE203677 T1 AT E203677T1 AT 96112524 T AT96112524 T AT 96112524T AT 96112524 T AT96112524 T AT 96112524T AT E203677 T1 ATE203677 T1 AT E203677T1
Authority
AT
Austria
Prior art keywords
vaccines
pathogen
legionellosis
production
hosts
Prior art date
Application number
AT96112524T
Other languages
English (en)
Inventor
Marcus A Horwitz
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE203677T1 publication Critical patent/ATE203677T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT96112524T 1988-08-16 1989-08-15 Legionellosis-impfstoffe und verfahren zur deren herstellung ATE203677T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07232664 US5108745B1 (en) 1988-08-16 1988-08-16 Tuberculosis and legionellosis vaccines and methods for their production

Publications (1)

Publication Number Publication Date
ATE203677T1 true ATE203677T1 (de) 2001-08-15

Family

ID=22874048

Family Applications (2)

Application Number Title Priority Date Filing Date
AT96112524T ATE203677T1 (de) 1988-08-16 1989-08-15 Legionellosis-impfstoffe und verfahren zur deren herstellung
AT89910005T ATE159857T1 (de) 1988-08-16 1989-08-15 Legionellosis-impfstoffe und verfahren zur herstellung

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT89910005T ATE159857T1 (de) 1988-08-16 1989-08-15 Legionellosis-impfstoffe und verfahren zur herstellung

Country Status (7)

Country Link
US (1) US5108745B1 (de)
EP (2) EP0753310B1 (de)
JP (1) JP2841094B2 (de)
AT (2) ATE203677T1 (de)
CA (1) CA1337333C (de)
DE (2) DE68928432T2 (de)
WO (1) WO1990001944A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6509151B1 (en) * 1993-09-02 2003-01-21 Cornell Research Foundation, Inc. DNA molecule encoding for cellular uptake of Mycobacterium tuberculosis and uses thereof
US6818223B2 (en) * 1993-11-23 2004-11-16 The Regents Of The University Of California Abundant extracellular products and methods for their production and use
US6752993B1 (en) 1993-11-23 2004-06-22 The Regents Of The University Of California Abundant extracellular product vaccines and methods for their production and use
US7300660B2 (en) * 1993-11-23 2007-11-27 The Regents Of The University Of California Abundant extracellular products and methods for their production and use
DE69435138D1 (de) 1993-11-23 2008-10-23 Univ California Reichlich vorhandene extrazelluläre produkte und methoden zu ihrer herstellung sowie ihre verwendung
JPH11506320A (ja) * 1995-05-23 1999-06-08 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 豊富な細胞外産物、ならびにそれらを産生および使用するための方法
RU2124208C1 (ru) * 1995-06-07 1998-12-27 Государственный научный центр прикладной микробиологии Диагностикум легионеллезный и способ его получения
US6592877B1 (en) 1995-09-01 2003-07-15 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6338852B1 (en) 1995-09-01 2002-01-15 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6458366B1 (en) * 1995-09-01 2002-10-01 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6290969B1 (en) 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
RU2129279C1 (ru) * 1995-11-23 1999-04-20 Государственный научный центр прикладной микробиологии Диагностикум для идентификации легионелл в клиническом материале и объектах внешней среды и способ его получения
US6013660A (en) * 1996-10-02 2000-01-11 The Regents Of The University Of California Externally targeted prophylactic and chemotherapeutic method and agents
US6072048A (en) 1997-03-10 2000-06-06 Cornell Research Foundation, Inc. DNA molecule encoding for cellular uptake of Mycobacterium tuberculosis and uses thereof
AU7166798A (en) 1997-05-06 1998-11-27 Cornell Research Foundation Inc. Dna molecule conferring on (mycobacterium tuberculosis) resistance against antimicrobial reactive oxygen and nitrogen intermediates
US6465633B1 (en) 1998-12-24 2002-10-15 Corixa Corporation Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis
US8143386B2 (en) * 1999-04-07 2012-03-27 Corixa Corporation Fusion proteins of mycobacterium tuberculosis antigens and their uses
AU4985900A (en) * 1999-05-04 2000-11-17 Public Health Research Institute Of The City Of New York, Inc., The Secreted proteins of (mycobacterium tuberculosis) and their use as vaccines and diagnostic reagents
EP1229931A4 (de) * 1999-10-07 2003-05-28 Corixa Corp Fusionsproteine aus mycobacterium tuberculosis
AU2001241738A1 (en) * 2000-02-25 2001-09-03 Corixa Corporation Compounds and methods for diagnosis and immunotherapy of tuberculosis
GB0012258D0 (en) 2000-05-19 2000-07-12 Fujitsu Ltd Transmission rate changes in communications networks
DE60139963D1 (de) * 2000-06-20 2009-10-29 Corixa Corp Fusionsproteine aus mycobakterium tuberculosis
US7026465B2 (en) 2002-02-15 2006-04-11 Corixa Corporation Fusion proteins of Mycobacterium tuberculosis
WO2004006952A2 (en) * 2002-07-13 2004-01-22 Statens Serum Institut Therapeutic tuberculosis vaccines
US20060142251A1 (en) * 2002-11-15 2006-06-29 Gunther Harth Anti-microbial agents derived from methionine sulfoximine analogues
US7901932B2 (en) * 2005-03-17 2011-03-08 Phigenics, Llc Methods and compositions for rapidly detecting and quantifying viable Legionella
MX2007011189A (es) * 2005-03-17 2008-01-16 Phigenics Llc Deteccion y cuantificacion rapida de legionella viable.
US20100015171A1 (en) 2008-07-15 2010-01-21 Statens Serum Institute Vaccines comprising tb 10.4
JP2022106353A (ja) * 2021-01-07 2022-07-20 住友金属鉱山株式会社 硫酸澱物保管容器の傾転治具

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4514509A (en) * 1981-09-21 1985-04-30 Indiana University Foundation Method for the diagnosis of Legionnaires' disease
GB8301600D0 (en) * 1983-01-21 1983-02-23 Btp Cocker Chem Ltd Control of legionella pneumophila in water systems
FR2541304A1 (fr) * 1983-02-21 1984-08-24 Centre Nat Rech Scient Anticorps monoclonaux anti-legionella, procede d'obtention et application au diagnostic de pneumonies
US4722891A (en) * 1984-06-20 1988-02-02 Board Of Regents, The University Of Texas System Methods and compositions for detection of Legionnaires' disease

Also Published As

Publication number Publication date
JPH04501107A (ja) 1992-02-27
EP0753310A1 (de) 1997-01-15
EP0432203B1 (de) 1997-11-05
EP0432203A4 (en) 1991-11-06
US5108745B1 (en) 1998-06-30
DE68929318D1 (de) 2001-09-06
EP0753310B1 (de) 2001-08-01
US5108745A (en) 1992-04-28
ATE159857T1 (de) 1997-11-15
DE68929318T2 (de) 2002-05-08
EP0432203A1 (de) 1991-06-19
DE68928432D1 (de) 1997-12-11
DE68928432T2 (de) 1998-03-05
WO1990001944A1 (en) 1990-03-08
CA1337333C (en) 1995-10-17
JP2841094B2 (ja) 1998-12-24

Similar Documents

Publication Publication Date Title
ATE203677T1 (de) Legionellosis-impfstoffe und verfahren zur deren herstellung
FI113969B (fi) Menetelmä CD40:n liukoisen ligandin valmistamiseksi, sitä koodaava nukleiinihappo ja sen käyttö
ES2092306T3 (es) Adyuvante para vacunas.
ES8203226A1 (es) Procedimiento de preparar complejos vacunantes por reaccion de arn ribonosales y de antigenos especificos.
ATE127345T1 (de) Stressproteine und verwendungen dafür.
ATE287947T1 (de) Orale immunisierung durch verwendung von transgenen pflanzen
HUP9900061A1 (hu) Alumínium-foszfátra adszorbeált konjugált poliszacharid antigént tartalmazó vakcinakompozíciók
CA2231603A1 (en) Chicken interleukin-15 and uses thereof
DE3806565A1 (de) Virusmodifizierte tumorvakzinen fuer die immuntherapie von tumormetastasen
ES520259A0 (es) Un procedimiento para preparar un complejo inmunogeno no covalentes de polisacarido-proteina, y obtenido a partir de capsulas bacterianas.
ES543026A0 (es) Un metodo para preparar una vacuna pra inducir inmunidad a la tosferina.
FI875015A0 (fi) Vaccin mot juverinflammation.
DE69030099D1 (de) Verfahren zur herstellung von impfstoffen oder toxoiden
DE69333588D1 (de) Verfahren zur verstärkung zellularer immunantworten
EP0023731A3 (de) Verfahren zur Herstellung polyvalenter Virus-Impfstoffe in einem Einzelzellsystem, solche polyvalenten Impfstoffe und ihre Verwendung
FR2646776B1 (fr) Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella
AT378947B (de) Verfahren zur herstellung eines an proteinen und vitaminen reichen produktes sowie einrichtung zur durchfuehrung des verfahrens
DE3774308D1 (de) Verfahren zum herstellen von brennbaren gegenstaenden durch tiefziehen von brennbaren papierscheiben mit einer elastischen patrize und vorrichtung zum durchfuehren des verfahrens.
AT364813B (de) Verfahren zur herstellung von alpha-aryl-alpha, alpha-di(omega-aminoalkyl)acetamiden mit disubstituierter aminogruppe
DK0542895T3 (da) Krydsreaktiv influenza A immunisering
ATE91131T1 (de) Verfahren zum extrahieren von membranantigenen mit immunogenen eigenschaften aus humanen neoplastischen zellen und so erhaltene produkte.
BE855776A (fr) Vaccin antiparasitaire par voie orale, son procede de preparation et sa methode d'application chez les mammiferes
DD129805A1 (de) Verfahren zur herstellung von viruslebendimpfstoffen,insbesondere aujeszky-lebendimpfstoff
ATE152916T1 (de) Die verwendung von anti-helminth impfstoffen zur kontrolle von parasitären krankheiten, die mit einem verlust der natürlichen immunität assoziiert sind
BG47346A3 (en) Method for preparing of dialkyldichlorsuccinates

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties